Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;21(6):723-736.
doi: 10.1007/s10741-016-9565-4.

Stem cells and diabetic cardiomyopathy: from pathology to therapy

Mingfei Liu  1 , Han Chen  1 , Jun Jiang  1 , Zhaocai Zhang  2 , Chen Wang  1 , Na Zhang  1 , Liang Dong  1 , Xinyang Hu  1 , Wei Zhu  1 , Hong Yu  1 , Jian'an Wang  3
Affiliations
Review

Stem cells and diabetic cardiomyopathy: from pathology to therapy

Mingfei Liu et al. Heart Fail Rev. 2016 Nov.

Abstract

The worldwide increase trend in the prevalence of diabetes has highlighted the need for increased research efforts into treatment options for both the disease itself and its associated complications. Diabetes has been widely recognized as a major risk factor for cardiovascular diseases, such as coronary heart disease and hypertension. Diabetic cardiomyopathy (DCM) is a main complication of diabetes, contributing to specific forms of heart failure independent from ischemia or hypertension. Without considerably effective approaches, a dire need exists to further explore the mechanisms and potential therapeutic strategies to prevent or reverse the progression of DCM. In the past decades, stem cell-based therapies have held promises to various diseases including DCM. The aim of the present review was to summarize the current literature with regard to the pathological changes of diabetic cardiomyopathy, endogenous stem cells in diabetes, and the exogenous stem cells transplantation for DCM. If the best use is made of the advantages of stem cells and their mechanism of action is explicitly explored, stem cell-based therapies could served as an important tool for the prevention and treatment of DCM patients.

Keywords: Cell therapy; Diabetic cardiomyopathy; Heart failure; Stem cell.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Circ Res. 2012 Feb 17;110(4):624-37 - PubMed
    1. J Clin Invest. 2007 May;117(5):1249-59 - PubMed
    1. Int J Mol Med. 2012 Dec;30(6):1313-20 - PubMed
    1. Cell Transplant. 2016;25(9):1653-1663 - PubMed
    1. Stem Cell Rev. 2013 Jun;9(3):254-65 - PubMed

Publication types

LinkOut - more resources

-